News about stock split

Eli Lilly has seen its stock rise more than 300% over five years, driven by demand for GLP-1 drugs such as Mounjaro and Zepbound, and reached record levels above $1,200 in recent months, now trading above $1,160. The article explains that stock splits increase the number of shares and lower the price per share, making stocks accessible to more investors without changing a company's fundamentals. Lilly has completed four splits, but the most recent was nearly 30 years ago, and its shares have advanced 25% over the past six months, coinciding with the launch of its GLP-1 pill Foundayo. Lilly is the U.S. market leader with a 60% share in a GLP-1 market expected to reach nearly $100 billion by the end of the decade, and the author considers a split announcement quite possible.

Market capitalization is the total value of a company's outstanding shares, calculated by multiplying the share price by the number of shares outstanding; the article uses Nvidia, the world's largest company at about $5.5 trillion, as an example, with shares near $229 and 24.3 billion shares outstanding. Stocks are grouped by market cap into micro-cap ($50 million to $250 million), small-cap ($250 million to $2 billion), mid-cap ($2 billion to $10 billion), large-cap ($10 billion to $200 billion) and mega-cap ($200 billion and above), each with different growth and risk profiles, and many indexes and ETFs are built around these sizes. A stock split does not change market cap, the article notes, citing CrowdStrike's 4-for-1 split in July, when its price fell from $772.74 to $193.19. The S&P 500 requires a minimum market cap of $20.5 billion and reviews its holdings quarterly.